Stocks
Mallinckrodt plcMNK
AMEXHealthcareBiotechnology$0.34-14.97%
Specializing in specialty pharmaceuticals and biopharmaceuticals, this company focuses on developing and commercializing treatments for rare diseases and autoimmune conditions. Investors monitor its performance due to its niche market focus and potential for high-impact therapies.
Market Cap: $4.5M52W Range: $0.30 – $16.00
Congressional Interest in Mallinckrodt plc (MNK)
4 members of Congress have disclosed 20 trades in Mallinckrodt plc (MNK), a Healthcare company. The buy/sell breakdown shows 14 purchases versus 6 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
20
Unique Politicians
4
Buys
14
Sells
6
Who in Congress Is Trading MNK?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2021-09-05 | Thomas Suozzi | sell | $1K – $15K |
| 2021-08-25 | Thomas Suozzi | buy | $1K – $15K |